INSULET OMNIPOD 5 USER MANUAL Pdf Download (2024)

FAQs

Has Omnipod 5 killed anyone? ›

Omnipod malfunction results in death

Overdoses of insulin can lead to harm or even death, as seen in the tragic fatal negligence case of a 5-year-old boy in 2019 who was given ten times the amount of insulin by a junior doctor in Rotherham. Another case relating to an Omnipod device was the death of Paul McNairney.

The Pod can hold up to 200 units of insulin; it requires a minimum of 85 units of insulin to begin operation. Simply fill the Pod with the amount of insulin you will need while wearing it, up to 200 units. Where on my body can I wear the Pod?

Training is essential and must be completed before using the Omnipod 5 System.

Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help manage glucose levels, reduce hypoglycemia, and increase time in range. For optimal glucose results, it is necessary to assess your initial Omnipod 5 settings with your healthcare provider.

To continue bringing our users the latest in Omnipod technology, we have made the decision to discontinue the Omnipod Insulin Management System (also known as Omnipod Eros, Omnipod UST400, or Omnipod “Classic”) in the United States as of December 31, 2023.

The Omnipod 5 Automated Insulin Delivery System is compatible with the following U-100 insulins: NovoLog®, Humalog®, and Admelog®. Device components including the Pod, Sensor, and Transmitter must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment.

Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%.

NovoLog, Humalog, and Admelog are compatible with the Omnipod 5 System for use up to 72 hours (3 days). Follow your healthcare provider's directions for how often to replace the Pod.

The Dexcom G6 and Dexcom G7 receivers are not compatible with the Omnipod 5 System. Can the Omnipod 5 System be used without a CGM? The Omnipod® 5 System can be used with or without a continuous glucose monitor, but to benefit from automated insulin delivery, it must be paired with a compatible CGM.

Flying with diabetes devices

The Bluetooth® setting remains enabled in the Omnipod PDM/Controller's aeroplane mode so you can communicate with your Pod. Your glucose sensor will still work if your phone is in aeroplane mode, and you can use it during the flight - just remember to keep your Bluetooth® on.

How to get free Omnipod 5? ›

Eligibility criteria: Subject to program limitations and terms and conditions, the Omnipod 5 10-day Free Trial Program (the “Program”) is open to patients who have a valid Omnipod 5 and Dexcom G6 prescription and who have commercial or private insurance, including plans available through state and federal healthcare ...

The Omnipod 5 App sends and receives information from the Pod using Bluetooth wireless technology and therefore cellular connectivity does not impact insulin delivery.

Possible causes include:

Inadequate insulin dose. Rebound from a low blood glucose. Delayed stomach (gastric) emptying. Taking too little insulin because of fear of low blood sugars.

The Omnipod 5 Pods are equipped with SmartAdjust™ technology that can receive sensor glucose values and use those values to automate insulin delivery. The Pod is wearable, lightweight, holds up to 200 units of insulin, and is waterproof**.

To establish communication to the Pod without delivering a command, simply swipe or tap the “Pod Info” tab on the Omnipod DASH® PDM Home screen. This allows information such as how much insulin is left in the Pod to be updated on the Omnipod DASH® PDM.

The Omnipod 5 System uses CGM values and trends to calculate insulin delivery. If the CGM values are inaccurate, the System could deliver an inaccurate dose of insulin which can lead to hypoglycemia or hyperglycemia. Wearing a Pod might cause infection.

Insulet's recall — a correction, not a product removal — affects software versions 1.1-1.2. 3 for the Omnipod 5 automated insulin delivery system. It distributed the software between April 20, 2023, and Dec. 20, 2023.

Approx. 76 of the pods have worked normally, resulting in a 28% failure rate (29/105 total pods to date).

In this Action, Lead Plaintiffs allege that Defendants made materially false and misleading statements to investors touting the quality of the OmniPod Eros, the successful launch of the product, customers' broad acceptance of the product, and the high rate of new patient starts during the Settlement Class Period.